Quarter Comparison
Revenue
Operating Income
Gross Margin
Net Margin
Income Statement
Cash Flow Statement
Balance Sheet
Earnings Release
EX-99.1 2 ex99-1.htm EX-99.1 Exhibit 99.1 Xtant Medical Reports Second Quarter 2026 Financial Results Launched Trivium™ Shaped, an extension of its Trivium line of premium, next-generation demineralized bone matrix allograft for bone grafting procedures Company to host investor conference call and w
EX-99.1 2 ex99-1.htm EX-99.1 Exhibit 99.1 Xtant Medical Reports Second Quarter 2026 Financial Results Launched Trivium™ Shaped, an extension of its Trivium line of premium, next-generation demineralized bone matrix allograft for bone grafting procedures Company to host investor conference call and webcast today, August 11 th , at 8:30am ET BELGRADE, Mont., August 11, 2026 — Xtant Medical Holdings, Inc. (NYSE American: XTNT), a medical technology company focused on surgical solutions for spinal and other orthopedic conditions, today reported financial and operating results for the second quarter ended June 30, 2026. Second Quarter 2026 Financial Highlights ● Generated total revenue of $23.0 million for the second quarter of 2026, as compared to $35.4 million for the second quarter of 2025. The decline in revenue relates primarily to the sale of the non-core Coflex/CoFix assets and interna...
Source
Exhibit EX-99.1
0001493152-26-036979
Filed August 11, 2026 at 11:05 AM UTC. The figures above are from the audited statements, not from this release.